Position in ERAS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$9,054,796
+$7,020,791 QoQ
Shares Held
559,629
+2.4% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 81.5661804516921.ToString("F0")%
Shared 0.ToString("F0")%
None 18.4338195483079.ToString("F0")%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,202,987,460 across 269 Biotechnology names. ERAS ranks #63 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in ERAS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,054,796 | 559,629 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,034,005 | 546,776 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,251,178 | 573,935 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $705,096 | 555,194 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $751,127 | 548,269 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,367,494 | 544,819 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,391,072 | 509,551 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $926,274 | 392,490 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $536,960 | 260,661 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $602,959 | 283,080 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $515,506 | 261,679 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $711,270 | 257,707 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $733,018 | 243,528 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $913,348 | 211,914 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,781,083 | 228,344 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,047,376 | 188,039 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,786,159 | 207,693 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,598,849 | 102,622 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,066,792 | 50,273 | Shares | Defined | 2021-11-18 | |
| No filing history on record for this holder in this stock. | ||||||